CIK 0001501697
- Non-accelerated filer
- Smaller reporting company
X4 Pharmaceuticals, Inc
Sign in to watch- Ticker
- XFOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273181608
- Phone
- +1 857-529-8300
- Business address
- 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Former names
- Arsanis, Inc.
- Open-market buys, last 90 days
- $11,884
- in 1 filing
- Open-market sales, last 90 days
- $33,658
- in 1 filing
Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-14 | Ragan Paula President and CEO | Grant or award | +44,826 | 253,738 | ||
| 2020-08-14 | Meisner Derek M General Counsel | Grant or award | +12,500 | 12,500 | ||
| 2020-08-03 | Ragan Paula President and CEO | Sale | −2,400 | $7.45 | $18K | 208,912 |
| 2020-07-02 | Ragan Paula President and CEO | Sale | −2,400 | $9.05 | $22K | 211,312 |
| 2020-06-30 | Mostafa Adam S. | Sale | −1,725 | $9.04 | $16K | 8,839 |
| 2020-06-30 | Mostafa Adam S. | Shares withheld for taxes | −916 | $9.32 | $9K | 7,923 |
| 2020-06-10 | Skerlj Renato Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2020-06-10 | Aliski William Director | Grant or award · Stock Option (right to buy) | +3,427 | 3,427 | ||
| 2020-06-10 | Russo Rene Director | Grant or award · Stock Option (right to buy) | +3,427 | 3,427 | ||
| 2020-06-10 | WYZGA MICHAEL S Director | Grant or award · Stock Option (right to buy) | +3,427 | 3,427 | ||
| 2020-06-10 | Stewart Murray Director | Grant or award · Stock Option (right to buy) | +3,427 | 3,427 | ||
| 2020-06-10 | MCGIRR DAVID W J Director | Grant or award · Stock Option (right to buy) | +3,427 | 3,427 | ||
| 2020-06-10 | Bridger Gary Director | Grant or award · Stock Option (right to buy) | +3,427 | 3,427 | ||
| 2020-06-03 | Ragan Paula President and CEO | Sale | −9,707 | $8.88 | $86K | 213,712 |
| 2020-06-02 | Ragan Paula President and CEO | Sale | −2,400 | $8.65 | $21K | 223,419 |
| 2020-06-01 | Ragan Paula President and CEO | Sale | −4,275 | $8.63 | $37K | 225,819 |
| 2020-05-04 | Ragan Paula President and CEO | Sale | −2,400 | $8.92 | $21K | 230,094 |
| 2020-04-02 | Ragan Paula President and CEO | Sale | −2,400 | $8.40 | $20K | 232,494 |
| 2020-03-02 | Ragan Paula President and CEO | Sale | −2,400 | $10.64 | $26K | 234,894 |
| 2019-11-26 | Meisner Derek M General Counsel | Grant or award · Stock Option (right to buy) | +55,000 | 55,000 |
Page 12 of 25 · 490 trades